15.21
Denali Therapeutics Inc Aktie (DNLI) Neueste Nachrichten
FDA Delays Decision Date For Denali Therapeutics' Lead Drug Candidate - Benzinga
FDA Extends Review of DNLI's Hunter Syndrome Drug by Three Months - Yahoo Finance
Denali Therapeutics Inc Announces FDA Review Extension for Tividenofusp Alfa - TradingView
Stifel reiterates Buy rating on Denali Therapeutics stock amid FDA review delay - Investing.com
Is Denali Therapeutics Inc a good long term investmentBullish Engulfing Patterns & Low Cost Stock Picks - earlytimes.in
Denali Therapeutics gets FDA review extension for tividenofusp alfa - Seeking Alpha
Denali Therapeutics announces FDA review extension of BLA for Tividenofusp alfa - MarketScreener
Denali Therapeutics Announces FDA Review Extension Of BLA For Tividenofusp Alfa - TradingView
Denali Therapeutics Announces Extension of FDA Review Timeline for Tividenofusp Alfa in Hunter Syndrome Treatment - Quiver Quantitative
FDA extends review of Denali’s Hunter syndrome treatment - Investing.com
Denali Therapeutics Announces FDA Review Extension of BLA - GlobeNewswire
Denali Therapeutics Announces FDA Review Extension of BLA for Tividenofusp Alfa for the Treatment of MPS II (Hunter Syndrome) - Stock Titan
Is Denali Therapeutics Inc. stock a dividend growth opportunity2025 Market Overview & Safe Entry Momentum Stock Tips - newser.com
Will Denali Therapeutics Inc. stock rally after Fed decisionsStop Loss & Capital Protection Trade Alerts - newser.com
Published on: 2025-10-13 08:56:53 - earlytimes.in
Understanding Denali Therapeutics Inc.’s price movementMarket Risk Analysis & Low Volatility Stock Suggestions - newser.com
How to forecast Denali Therapeutics Inc. trends using time seriesWeekly Trend Summary & Advanced Swing Trade Entry Alerts - newser.com
Can Denali Therapeutics Inc. (4DN) stock resist broad market declinesMarket Weekly Review & Weekly Top Stock Performers List - newser.com
Tick level data insight on Denali Therapeutics Inc. volatilityTrend Reversal & Reliable Volume Spike Alerts - newser.com
Forecasting Denali Therapeutics Inc. price range with options data2025 Year in Review & Fast Entry High Yield Stock Tips - newser.com
What institutional flow reveals about Denali Therapeutics Inc.Quarterly Growth Report & Verified Swing Trading Watchlist - newser.com
Will Denali Therapeutics Inc. bounce back from current supportWeekly Trade Review & High Conviction Buy Zone Alerts - newser.com
Denali Therapeutics' (DNLI) "Sell (D-)" Rating Reaffirmed at Weiss Ratings - MarketBeat
What the Next Quarters Forecast Means for Beacon Trusteeship Limited InvestorsQuarterly Earnings Review & Free Tools to Find Winning Stocks - earlytimes.in
Denali Therapeutics Inc 4DN Stock Analysis and ForecastSector Performance Review & Get Free Expert Trading Recommendations - earlytimes.in
How to monitor Denali Therapeutics Inc. with trend dashboardsJuly 2025 Opening Moves & Consistent Profit Trade Alerts - newser.com
Regression analysis insights on Denali Therapeutics Inc. performanceBull Run & Consistent Return Strategy Ideas - newser.com
Should you hold or exit Denali Therapeutics Inc. nowJuly 2025 Institutional & Verified Swing Trading Watchlist - newser.com
Visual analytics tools that track Denali Therapeutics Inc. performanceTake Profit & Weekly Breakout Stock Alerts - newser.com
Deutsche Bank sets $31 target for Denali Therapeutics stock - MSN
BofA Securities Maintains Denali Therapeutics(DNLI.US) With Buy Rating, Maintains Target Price $27 - 富途牛牛
Why Denali Therapeutics Inc. stock attracts global investorsPortfolio Risk Report & Free Expert Verified Stock Movement Alerts - newser.com
Published on: 2025-10-03 02:14:22 - newser.com
Published on: 2025-10-03 01:11:36 - newser.com
Here's Why We're Not Too Worried About Denali Therapeutics' (NASDAQ:DNLI) Cash Burn Situation - 富途牛牛
Denali Therapeutics (NASDAQ:DNLI) Trading 7.4% HigherHere's What Happened - MarketBeat
What drives Denali Therapeutics Inc 4DN stock priceSector Rotation Strategies & Low Risk Trading Growth - earlytimes.in
Published on: 2025-09-30 04:04:18 - newser.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):